Centre Testing International Group (300012) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2025 reached ¥1,286.78 million, up 7.96% year-over-year.

• Net profit attributable to shareholders was ¥136.19 million, a 2.75% increase year-over-year.

• EBITDA rose 4.37% to ¥280.43 million compared to the same quarter last year.

• Operating cash flow improved significantly, with net outflow reduced by 47.10% year-over-year.

Financial highlights

• Gross margin increased as cost control measures took effect, with operating costs rising slower than revenue.

• Net profit margin remained stable, with basic and diluted EPS at ¥0.0814, up from ¥0.0791 year-over-year.

• Total assets at quarter-end were ¥9,141.33 million, down 3.29% from year-end 2024.

• Shareholders’ equity rose 1.95% to ¥7,048.20 million compared to year-end 2024.

• Non-recurring gains totaled ¥11.19 million, mainly from government subsidies and investment income.

Outlook and guidance

• Management expects continued revenue growth driven by increased market demand and ongoing investments in capacity.

• Focus remains on improving profitability and cash flow through operational efficiency.